Bio-Plex 200 (Allergens)

The contract involves funding for the acquisition of a Bio-Plex multiplex system, a crucial instrument for the xMAP Food Allergen Detection Assay developed by the FDA. This advanced immunoassay enables the simultaneous detection of multiple food allergens, including gluten, within a single test. The procurement aims to replace outdated instrumentation that is nearing the end of its operational life, ensuring the continued ability to conduct method development and validation studies effectively. This investment supports the FDA's ongoing efforts in food allergen detection and aligns with the agency's mission to protect public health. The contract falls under the NAICS code 541990 and is managed by the Food and Drug Administration, with points of contact available for acquisition liaison and contracting officer roles. This system's updated capabilities will enhance the FDA's analytical efficiency and reliability in allergen detection.